Safety Study of Live Attenuated Influenza Vaccine, CodaVax, Delivered Via Intranasal Spray
Clinical trial NCT04146623 · COMPLETED
Trial details
- NCT number
- NCT04146623
- Sponsor
- Codagenix, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-07
- Primary completion
- 2020-10-11
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.